Irtc.O

The company maintains a debt-free capital structure with a debt-to-equity ratio of 0.0, supported by cash and equivalents of $236.0 million against total assets of $1.02 billion. Despite holding significant liquidity, the firm reports a negative return on equity of -18.19% and a negative return on assets of -2.72%, indicating that current asset utilization is not generating positive shareholder returns. The price-to-book ratio stands at 25.89, reflecting a high market valuation relative to the book value of $152.7 million in total equity.

Profitability remains negative, with an operating income of -$57.4 million and net income of -$44.6 million on revenues of $747.1 million. The gross profit of $527.3 million suggests a gross margin of approximately 70.6%, which is typical for high-margin medical device companies, but operating expenses exceed gross profits, leading to an operating loss. The enterprise value to revenue multiple is 4.72, while the EV/EBITDA is negative at -90.61, highlighting the market's pricing of future growth expectations over current earnings.

Segment and geographic revenue breakdowns are not provided in the available data, preventing an analysis of revenue concentration or regional exposure. The company's revenue mix is therefore opaque, and no specific segment performance can be evaluated against industry peers.

Growth trajectory analysis is limited by the absence of historical period data in the input. Without five-year annual or eight-quarter quarterly revenue and net income trends, it is not possible to assess the momentum of revenue growth or the consistency of profitability improvements over time.

Risk assessment indicates low liquidity risk and low dilution risk, with no immediate filing-based flags detected. The company's cash position of $236.0 million provides a buffer against short-term obligations, and the absence of debt reduces financial distress risk. However, the negative earnings and high valuation multiples suggest that the market is pricing in significant future growth, which carries execution risk.

Recent observations include strong analyst sentiment, with a mean recommendation of 1.47 (strong buy) and a mean price target of $178.00, implying substantial upside from the current market price of $122.44. There are 8 strong buy and 7 buy ratings, with no hold ratings, indicating high confidence among analysts. No significant news events or filing observations were detected beyond the reconciler enqueue notices.

Revenue $199.4M, +25,7% YoY; Operating income +50,3% YoY.

• ▍Revenue $199.4M, +25,7% YoY
• ▍Operating income +50,3% YoY
• ▍Net income +54,6% YoY
• ▍Free cash flow +54,8% YoY
• ▍Net margin -7.0%

Revenue $208.9M, +27,1% YoY; Operating income +156,0% YoY.

• ▍Revenue $208.9M, +27,1% YoY
• ▍Operating income +156,0% YoY
• ▍Net income +518,5% YoY
• ▍Free cash flow +69,1% YoY
• ▍Net margin 2.7%

Revenue $192.9M, +30,7% YoY; Operating income +83,2% YoY.

• ▍Revenue $192.9M, +30,7% YoY
• ▍Operating income +83,2% YoY
• ▍Net income +88,7% YoY
• ▍Free cash flow +77,1% YoY
• ▍Net margin -2.7%

Revenue $186.7M, +26,1% YoY; Operating income +18,6% YoY.

• ▍Revenue $186.7M, +26,1% YoY
• ▍Operating income +18,6% YoY
• ▍Net income +29,3% YoY
• ▍Free cash flow +16,7% YoY
• ▍Net margin -7.6%

Revenue $158.7M; Operating income -$32.6M.

• ▍Revenue $158.7M
• ▍Operating income -$32.6M
• ▍Net margin -19.3%

Revenue $164.3M; Operating income -$4.1M.

• ▍Revenue $164.3M
• ▍Operating income -$4.1M
• ▍Net margin -0.8%

Revenue $147.5M; Operating income -$50.3M.

• ▍Revenue $147.5M
• ▍Operating income -$50.3M
• ▍Net margin -31.3%

Revenue $148.0M; Operating income -$23.0M.

• ▍Revenue $148.0M
• ▍Operating income -$23.0M
• ▍Net margin -13.6%

Revenue $747.1M, +26,2% YoY; Operating income +53,4% YoY.

• ▍Revenue $747.1M, +26,2% YoY
• ▍Operating income +53,4% YoY
• ▍Net income +60,7% YoY
• ▍Free cash flow +50,4% YoY
• ▍Net margin -6.0%

Revenue $591.8M, +20,1% YoY; Operating income +1,6% YoY.

• ▍Revenue $591.8M, +20,1% YoY
• ▍Operating income +1,6% YoY
• ▍Net income +8,2% YoY
• ▍Free cash flow +4,0% YoY
• ▍Net margin -19.1%

Revenue $492.7M, +19,9% YoY; Operating income −10,0% YoY.

• ▍Revenue $492.7M, +19,9% YoY
• ▍Operating income −10,0% YoY
• ▍Net income −6,2% YoY
• ▍Free cash flow −11,2% YoY
• ▍Net margin -25.0%

Revenue $410.9M, +27,3% YoY; Operating income −13,8% YoY.

• ▍Revenue $410.9M, +27,3% YoY
• ▍Operating income −13,8% YoY
• ▍Net income −14,6% YoY
• ▍Free cash flow −10,9% YoY
• ▍Net margin -28.3%